Symposium 2026 – 58th annual symposium

Programme Committee

PROGRAMME

[ 2:00-3:30 pm ]

STC Board of Directors Meeting

STC Board Members Only

—
[ 4:00-5:00 pm ]

ICT-2028 Vancouver 2nd Planning Meeting

ICT Planning Committee Members Only

—
[ 6:30-10:00 pm ]

Meet & Greet @ TBC

All Attendees

[ 8:15 – 8:30 am ]
Welcome and Opening Remarks

—

[ 8:30-9:45 am ]
SESSION I
The Foundational Science of New Approach Methodologies (NAMs).

Focusing on the tools that generate high-quality biological data.
Chair and co-chair : TBD

8:30 – 8:55 > Vascularization: A Foundational Requirement for Predictive Toxicology NAMs
Karolina Valente, VoxCell; Victoria, British Columbia, Canada

8:55 – 9:20 > New Frontiers in NAMs Applications: Cutting Edge Strategies for Immunogenicity, Toxicology of Pharmaceutical Products and Functional Drug Safety Screening
Simon Authier, Charles River; Quebec, Canada

9:20 – 9:45 > New Techniques to Study Arsenic Binding to Proteins: From Molecular Interactions to New Approach Methodologies
Chris Le, University of Alberta; Edmonton, Alberta, Canada

—

[ 9:45 – 10:15 am ]
Coffee / Tea Break

—

[ 10:15-10:45 am ]
Gabriel Plaa Award

Introduction: TBD
—

[ 10:45-11:45 am ]
Plenary

Human-Relevant, Globally Connected: Toxicology’s Next Chapter.
Nicole Kleinstreuer,National Institutes of Health; Bethesda, Maryland, USA

—

[ 11:45 – 12:00 am ]
ICT2028 Update

Angela Hofstra
—

[ 12:00 am – 1:00 pm ]
Lunch

—

[ 1:00-1:50 pm ]
SESSION II
Computational and Predictive Toxicology.

AI-driven hazard prediction, modelling compound behavior, systems-based approaches for toxicity assessment.
Chair and co-chair : TBD

1:00 – 1:25 > Leveraging AI-Driven Stratification for Optimized Clozapine Safety in Treatment-Resistant Schizophrenia: Translating Real-World Evidence into Clinical Decision Support
Lusine Tonoyan, University of Alberta; Edmonton, Alberta, Canada

1:25 – 1:50 > Multi-Stage AI Workflows for Regulatory Toxicology: From Chemical Structure to Automated Risk Assessment
Thomas Allen Bozada Jr., Insilica Inc; USA

—

[ 1:50-2:20 pm ]
SESSION III
Short Oral Presentations, Selected Trainee Posters

Chair and co-chair : TBD
—

[ 2:20 – 2:30 am ]
Coffee / Tea Break

—

[ 2:30 – 4:00 pm ]
Poster Session

—

[ 4:00 – 5:00 pm ]
Trainee-Networking Session

—

Concurrent STC Annual Business Meeting – All STC Members

—

[ 6:30 pm ]
Reception & Awards

All attendees are welcome – Venue: TBD
finger food & refreshments provided and cash bar

[ 8:25 – 8:30 am ]
Opening Remarks

—

[ 8:15-9:45 am ]
SESSION IV
Exposure Science and Risk Assessment

Understanding human exposure, dose modelling, integrating diverse data for risk evaluation.
Chair and Co-chair: TBD

8:30 – 8:55 > The Alberta Biomonitoring Program: Tracking Environmental Exposure in Maternal and Child Populations
Amy MacDonald, Alberta Society for Human Toxicology; Calgary, Alberta, Canada

8:55 – 9:20 > Human Health Risk Assessment of Resource Projects in Western Canada
Karen Philllips, Alberta Society for Human Toxicology; Calgary, Alberta, Canada

9:20 – 9:50 > Henderson Award
Introduction: TBD

9:50 – 10:20 > Coffee / Tea Break

10:20 – 10:30 > Shaarika Sarasija
Humane World for Animals

10:30 – 10:55 > What the Sample Reveals: Drug Testing Data in Alberta
Penny Colbourne, Alberta Precision Labs; Edmonton, Alberta, Canada

11:00 – 12:00 > Poster session

—

[ 12:00 am – 1:00 pm ]
Lunch

—

[ 1:00-2:45 pm ]
SESSION V
Safety Assessment, Regulatory Perspectives, and Future Global Outlook

Exploring integrated testing strategies, validation of new methods for predictive toxicology, global regulatory frameworks and data sharing to facilitate NAMs acceptance internationally
Chair and Co-chair: TBD

1:00 – 1:25 > Barbara Hales Award
Introduction: TBD

1:25 – 1:50 > Update on Key CEPA Amendments and the Chemicals Management Plan
Robin Churchill, Health Canada; Ottawa, Ontario, Canada

1:50 – 2:20 > Deploying New Approach Methodologies (NAM) within a Computational Workflow for Enhanced Prioritization and Rapid Screening of Existing Chemicals in Canada
Matthew Gagne, Health Canada; Ottawa, Ontario, Canada
Virtual talk

2:20 – 2:45 > Session title to be confirmed
Konst Mroncz, Altasciences; Los Angeles, USA

—

[ 2:45 – 3:00 pm]
Closing Remarks